+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Nephrostomy Devices Market (2019-2025)

  • ID: 4848949
  • Report
  • Region: Europe
  • 84 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 3

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Coloplast Group
  • Olympus Corporation
  • Teleflex, Inc.
  • UreSil LLC
  • MORE
The Europe Nephrostomy Devices Market is expected to witness market growth of 7.6% CAGR during the forecast period (2019-2025). The prevalence of kidney stone disorder, increased requirement for minimally invasive surgical procedures, and risen awareness about the devices are some of the major factors that are influencing the market.

Nephrostomy is an opening that exists between the skin and the kidney. A nephrostomy tube that is passed from the back, is a thin plastic tube inserted through the skin, into the kidney, to the spot where urine is collected. The task of the tube is to drain the blocked urine. This enables the proper functioning of the kidney and protects it from further damage. Nephrostomy tubes help to clear out any infection. The entire procedure is guided by ultrasound and/or X-ray images (or pictures). Contrast has also injected the part of the kidney which collects urine. With this, the tube can easily drain the kidney to be inserted into the collecting system.

Based on Product, the market is segmented into Guidewires, Sheath Dilators, Nephrostomy Catheters, Drainage Tubes and Other Nephrostomy Devices. Based on End Use, the market is segmented into Hospital, Ambulatory Surgical Centers (ASCs) and Emergency Clinics. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Teleflex, Inc., Cook Medical, Inc. (Cook Group), Coloplast Group, Olympus Corporation, Argon Medical Devices, Inc., UreSil LLC, B. Braun Melsungen AG, Cardinal Health, Inc., and Becton, Dickinson and Company.

Scope of the Study

Market Segmentation:

By Product
  • Guidewires
  • Sheath Dilators
  • Nephrostomy Catheters
  • Drainage Tubes
  • Other Nephrostomy Devices
By End Use
  • Hospital
  • Ambulatory Surgical Centers (ASCs)
  • Emergency Clinics
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Boston Scientific Corporation
  • Teleflex, Inc.
  • Cook Medical, Inc. (Cook Group)
  • Coloplast Group
  • Olympus Corporation
  • Argon Medical Devices, Inc.
  • UreSil LLC
  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Becton, Dickinson and Company
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Coloplast Group
  • Olympus Corporation
  • Teleflex, Inc.
  • UreSil LLC
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Nephrostomy Devices Market, by Product
1.4.2 Europe Nephrostomy Devices Market, by End Use
1.4.3 Europe Nephrostomy Devices Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition: 2019-May-2015-Mar) Leading Players

Chapter 4. Europe Nephrostomy Devices Market by Product
4.1 Europe Guidewires Market by Country
4.2 Europe Sheath Dilators Market by Country
4.2.1 Europe Nephrostomy Catheters Market by Country
4.2.2 Europe Drainage Tubes Market by Country
4.2.3 Europe Other Nephrostomy Devices Market by Country

Chapter 5. Europe Nephrostomy Devices Market by End Use
5.1 Europe Hospital Market by Country
5.2 Europe Ambulatory Surgical Centers (ASCs) Market by Country
5.3 Europe Emergency Clinics Market by Country

Chapter 6. Europe Nephrostomy Devices Market by Country
6.1 Germany Nephrostomy Devices Market
6.1.1 Germany Nephrostomy Devices Market by Product
6.1.2 Germany Nephrostomy Devices Market by End Use
6.2 UK Nephrostomy Devices Market
6.2.1 UK Nephrostomy Devices Market by Product
6.2.2 UK Nephrostomy Devices Market by End Use
6.3 France Nephrostomy Devices Market
6.3.1 France Nephrostomy Devices Market by Product
6.3.2 France Nephrostomy Devices Market by End Use
6.4 Russia Nephrostomy Devices Market
6.4.1 Russia Nephrostomy Devices Market by Product
6.4.2 Russia Nephrostomy Devices Market by End Use
6.5 Spain Nephrostomy Devices Market
6.5.1 Spain Nephrostomy Devices Market by Product
6.5.2 Spain Nephrostomy Devices Market by End Use
6.6 Italy Nephrostomy Devices Market
6.6.1 Italy Nephrostomy Devices Market by Product
6.6.2 Italy Nephrostomy Devices Market by End Use
6.7 Rest of Europe Nephrostomy Devices Market
6.7.1 Rest of Europe Nephrostomy Devices Market by Product
6.7.2 Rest of Europe Nephrostomy Devices Market by End Use

Chapter 7. Company Profiles
7.1 Boston Scientific Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Collaborations, partnerships and agreements:
7.1.5.2 Acquisition and mergers:
7.1.5.3 Product launches:
7.2 Teleflex, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.1 Recent strategies and developments:
7.2.1.1 Acquisition and mergers:
7.2.1.2 Product launches:
7.2.1.3 Expansions:
7.3 Cook Medical, Inc. (Cook Group)
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Collaborations, partnerships and agreements:
7.3.2.2 Product launches:
7.3.2.3 Expansions:
7.4 Coloplast Group
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and mergers:
7.5 Olympus Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Collaborations, partnerships and agreements:
7.5.5.2 Product launches:
7.5.5.3 Acquisition and mergers:
7.6 Argon Medical Devices, Inc.
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Acquisition and mergers:
7.7 UreSil LLC
7.7.1 Company Overview
7.8 B. Braun Melsungen AG
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Collaborations, partnerships and agreements:
7.8.5.2 Acquisition and mergers:
7.9 Cardinal Health, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Recent strategies and developments:
7.9.4.1 Collaborations, partnerships and agreements:
7.9.4.2 Product launches:
7.1 Becton, Dickinson and Company
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Acquisition and mergers:
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Boston Scientific Corporation
  • Teleflex, Inc.
  • Cook Medical, Inc. (Cook Group)
  • Coloplast Group
  • Olympus Corporation
  • Argon Medical Devices, Inc.
  • UreSil LLC
  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Becton, Dickinson and Company
Note: Product cover images may vary from those shown
Adroll
adroll